Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Work and education interruption in long-term Hodgkin lymphoma survivors : an analysis among patients from nine EORTC-LYSA trials. / Juul, Sidsel J.; Rossetti, Sára; Kicinski, Michal; van der Kaaij, Marleen A.E.; Giusti, Francesco; Meijnders, Paul; Aleman, Berthe M.P.; Raemaekers, John M.M.; Kluin-Nelemans, Hanneke C.; Spina, Michele; Fermé, Christophe; Renaud, Loïc; Casasnovas, Olivier; Stamatoullas, Aspasia; André, Marc; Le Bras, Fabien; Plattel, Wouter J.; Henry-Amar, Michel; Hutchings, Martin; Maraldo, Maja V.

I: Acta Oncologica, Bind 62, Nr. 7, 2023, s. 744-752.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Juul, SJ, Rossetti, S, Kicinski, M, van der Kaaij, MAE, Giusti, F, Meijnders, P, Aleman, BMP, Raemaekers, JMM, Kluin-Nelemans, HC, Spina, M, Fermé, C, Renaud, L, Casasnovas, O, Stamatoullas, A, André, M, Le Bras, F, Plattel, WJ, Henry-Amar, M, Hutchings, M & Maraldo, MV 2023, 'Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials', Acta Oncologica, bind 62, nr. 7, s. 744-752. https://doi.org/10.1080/0284186X.2023.2195561

APA

Juul, S. J., Rossetti, S., Kicinski, M., van der Kaaij, M. A. E., Giusti, F., Meijnders, P., Aleman, B. M. P., Raemaekers, J. M. M., Kluin-Nelemans, H. C., Spina, M., Fermé, C., Renaud, L., Casasnovas, O., Stamatoullas, A., André, M., Le Bras, F., Plattel, W. J., Henry-Amar, M., Hutchings, M., & Maraldo, M. V. (2023). Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials. Acta Oncologica, 62(7), 744-752. https://doi.org/10.1080/0284186X.2023.2195561

Vancouver

Juul SJ, Rossetti S, Kicinski M, van der Kaaij MAE, Giusti F, Meijnders P o.a. Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials. Acta Oncologica. 2023;62(7):744-752. https://doi.org/10.1080/0284186X.2023.2195561

Author

Juul, Sidsel J. ; Rossetti, Sára ; Kicinski, Michal ; van der Kaaij, Marleen A.E. ; Giusti, Francesco ; Meijnders, Paul ; Aleman, Berthe M.P. ; Raemaekers, John M.M. ; Kluin-Nelemans, Hanneke C. ; Spina, Michele ; Fermé, Christophe ; Renaud, Loïc ; Casasnovas, Olivier ; Stamatoullas, Aspasia ; André, Marc ; Le Bras, Fabien ; Plattel, Wouter J. ; Henry-Amar, Michel ; Hutchings, Martin ; Maraldo, Maja V. / Work and education interruption in long-term Hodgkin lymphoma survivors : an analysis among patients from nine EORTC-LYSA trials. I: Acta Oncologica. 2023 ; Bind 62, Nr. 7. s. 744-752.

Bibtex

@article{6cd742884db747ecb8ed133966f18f14,
title = "Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials",
abstract = "Background: Disease-specific studies on the impact of Hodgkin lymphoma (HL) on education or work interruption and resumption are lacking. Material and methods: In a cross-sectional study conducted among long-term HL survivors enrolled from 1964 to 2004 in nine randomised EORTC-LYSA trials, the interruption and resumption of education/work was investigated. Survivors alive 5–44 years after diagnosis who were studying or working at time of diagnosis were included (n = 1646). Patient and treatment characteristics were obtained from trial records. Education and work outcomes were collected using the Life Situation Questionnaire. Logistic regression was used to model education or work interruption; Cox regression was used to study resumption rates. Results: Among survivors studying at time of diagnosis (n = 323), 52% (95% CI: 46–57%) interrupted their education; however, it was resumed within 24 months by 92% (95% CI: 87–96%). The probability of interruption decreased with time: the more recent the treatment era, the lower the risk (OR 0.70 per 10 years, 95% CI: 0.49–1.01). Treatment with radiotherapy (yes vs. no) was associated with a higher education resumption rate (HR 2.01, 95% CI 1.07–3.78) whereas age, sex, stage, radiotherapy field and chemotherapy were not. Among survivors working at time of diagnosis (n = 1323), 77% (95% CI: 75–79%) interrupted their work. However, it was resumed within 24 months by 86% (95% CI: 84%-88%). Women were more likely to interrupt their work as compared to men (OR 1.90, 95% CI: 1.44–2.51) and, when interrupted, less likely to resume work (HR 0.70, 95% CI: 0.61–0.80). Survivors with a higher educational level were less likely to interrupt their work (OR 0.68 for university vs. no high school, 95% CI: 0.46–1.03); and when interrupted, more likely to resume work (HR 1.50 for university vs. no high school, 95% CI: 1.21–1.86). Increasing age was also associated with lower resumption rates (HR 0.62 for age ≥50 vs. 18–29 years, 95% CI: 0.41–0.94). Conclusion: An interruption in education/work was common among long-term HL survivors. However, most of the survivors who interrupted their studies or work had resumed their activities within 24 months. In this study, no associations between survivors{\textquoteright} characteristics and failure to resume education were observed. Female sex, age ≥50 years, and a lower level of education were found to be associated with not resuming work after treatment for HL.",
keywords = "education, employment, Hodgkin lymphoma, survivorship, work",
author = "Juul, {Sidsel J.} and S{\'a}ra Rossetti and Michal Kicinski and {van der Kaaij}, {Marleen A.E.} and Francesco Giusti and Paul Meijnders and Aleman, {Berthe M.P.} and Raemaekers, {John M.M.} and Kluin-Nelemans, {Hanneke C.} and Michele Spina and Christophe Ferm{\'e} and Lo{\"i}c Renaud and Olivier Casasnovas and Aspasia Stamatoullas and Marc Andr{\'e} and {Le Bras}, Fabien and Plattel, {Wouter J.} and Michel Henry-Amar and Martin Hutchings and Maraldo, {Maja V.}",
note = "Publisher Copyright: {\textcopyright} 2023 Acta Oncologica Foundation.",
year = "2023",
doi = "10.1080/0284186X.2023.2195561",
language = "English",
volume = "62",
pages = "744--752",
journal = "Acta Oncologica",
issn = "1100-1704",
publisher = "Taylor & Francis",
number = "7",

}

RIS

TY - JOUR

T1 - Work and education interruption in long-term Hodgkin lymphoma survivors

T2 - an analysis among patients from nine EORTC-LYSA trials

AU - Juul, Sidsel J.

AU - Rossetti, Sára

AU - Kicinski, Michal

AU - van der Kaaij, Marleen A.E.

AU - Giusti, Francesco

AU - Meijnders, Paul

AU - Aleman, Berthe M.P.

AU - Raemaekers, John M.M.

AU - Kluin-Nelemans, Hanneke C.

AU - Spina, Michele

AU - Fermé, Christophe

AU - Renaud, Loïc

AU - Casasnovas, Olivier

AU - Stamatoullas, Aspasia

AU - André, Marc

AU - Le Bras, Fabien

AU - Plattel, Wouter J.

AU - Henry-Amar, Michel

AU - Hutchings, Martin

AU - Maraldo, Maja V.

N1 - Publisher Copyright: © 2023 Acta Oncologica Foundation.

PY - 2023

Y1 - 2023

N2 - Background: Disease-specific studies on the impact of Hodgkin lymphoma (HL) on education or work interruption and resumption are lacking. Material and methods: In a cross-sectional study conducted among long-term HL survivors enrolled from 1964 to 2004 in nine randomised EORTC-LYSA trials, the interruption and resumption of education/work was investigated. Survivors alive 5–44 years after diagnosis who were studying or working at time of diagnosis were included (n = 1646). Patient and treatment characteristics were obtained from trial records. Education and work outcomes were collected using the Life Situation Questionnaire. Logistic regression was used to model education or work interruption; Cox regression was used to study resumption rates. Results: Among survivors studying at time of diagnosis (n = 323), 52% (95% CI: 46–57%) interrupted their education; however, it was resumed within 24 months by 92% (95% CI: 87–96%). The probability of interruption decreased with time: the more recent the treatment era, the lower the risk (OR 0.70 per 10 years, 95% CI: 0.49–1.01). Treatment with radiotherapy (yes vs. no) was associated with a higher education resumption rate (HR 2.01, 95% CI 1.07–3.78) whereas age, sex, stage, radiotherapy field and chemotherapy were not. Among survivors working at time of diagnosis (n = 1323), 77% (95% CI: 75–79%) interrupted their work. However, it was resumed within 24 months by 86% (95% CI: 84%-88%). Women were more likely to interrupt their work as compared to men (OR 1.90, 95% CI: 1.44–2.51) and, when interrupted, less likely to resume work (HR 0.70, 95% CI: 0.61–0.80). Survivors with a higher educational level were less likely to interrupt their work (OR 0.68 for university vs. no high school, 95% CI: 0.46–1.03); and when interrupted, more likely to resume work (HR 1.50 for university vs. no high school, 95% CI: 1.21–1.86). Increasing age was also associated with lower resumption rates (HR 0.62 for age ≥50 vs. 18–29 years, 95% CI: 0.41–0.94). Conclusion: An interruption in education/work was common among long-term HL survivors. However, most of the survivors who interrupted their studies or work had resumed their activities within 24 months. In this study, no associations between survivors’ characteristics and failure to resume education were observed. Female sex, age ≥50 years, and a lower level of education were found to be associated with not resuming work after treatment for HL.

AB - Background: Disease-specific studies on the impact of Hodgkin lymphoma (HL) on education or work interruption and resumption are lacking. Material and methods: In a cross-sectional study conducted among long-term HL survivors enrolled from 1964 to 2004 in nine randomised EORTC-LYSA trials, the interruption and resumption of education/work was investigated. Survivors alive 5–44 years after diagnosis who were studying or working at time of diagnosis were included (n = 1646). Patient and treatment characteristics were obtained from trial records. Education and work outcomes were collected using the Life Situation Questionnaire. Logistic regression was used to model education or work interruption; Cox regression was used to study resumption rates. Results: Among survivors studying at time of diagnosis (n = 323), 52% (95% CI: 46–57%) interrupted their education; however, it was resumed within 24 months by 92% (95% CI: 87–96%). The probability of interruption decreased with time: the more recent the treatment era, the lower the risk (OR 0.70 per 10 years, 95% CI: 0.49–1.01). Treatment with radiotherapy (yes vs. no) was associated with a higher education resumption rate (HR 2.01, 95% CI 1.07–3.78) whereas age, sex, stage, radiotherapy field and chemotherapy were not. Among survivors working at time of diagnosis (n = 1323), 77% (95% CI: 75–79%) interrupted their work. However, it was resumed within 24 months by 86% (95% CI: 84%-88%). Women were more likely to interrupt their work as compared to men (OR 1.90, 95% CI: 1.44–2.51) and, when interrupted, less likely to resume work (HR 0.70, 95% CI: 0.61–0.80). Survivors with a higher educational level were less likely to interrupt their work (OR 0.68 for university vs. no high school, 95% CI: 0.46–1.03); and when interrupted, more likely to resume work (HR 1.50 for university vs. no high school, 95% CI: 1.21–1.86). Increasing age was also associated with lower resumption rates (HR 0.62 for age ≥50 vs. 18–29 years, 95% CI: 0.41–0.94). Conclusion: An interruption in education/work was common among long-term HL survivors. However, most of the survivors who interrupted their studies or work had resumed their activities within 24 months. In this study, no associations between survivors’ characteristics and failure to resume education were observed. Female sex, age ≥50 years, and a lower level of education were found to be associated with not resuming work after treatment for HL.

KW - education

KW - employment

KW - Hodgkin lymphoma

KW - survivorship

KW - work

U2 - 10.1080/0284186X.2023.2195561

DO - 10.1080/0284186X.2023.2195561

M3 - Journal article

C2 - 37039661

AN - SCOPUS:85152464693

VL - 62

SP - 744

EP - 752

JO - Acta Oncologica

JF - Acta Oncologica

SN - 1100-1704

IS - 7

ER -

ID: 396724936